Publication | Closed Access

Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [18F]FDG-PET tumour residual uptake at 42 Gy (RTEP7–IFCT-1402): a multicentre, randomised, controlled phase 2 trial

Adaptive RadiotherapyRadiation MedicineRadiation TherapyTreatment VerificationMedicineRadiation Therapy PlanningStandard RadiotherapyLung CancerComparative PlanningOncologyRadiation OncologyPhase 2Nuclear MedicineRadiologyHealth Sciences